CMS Proposes Strengthening Medicare Drug Price Negotiation Program
The Centers for Medicare and Medicaid Services (CMS) has proposed significant changes to the Medicare Drug Price Negotiation Program. These proposals aim to formally codify the program's existing requirements and address potential loopholes that drug manufacturers could exploit. The suggested modifications are intended to enhance the program's effectiveness.
The Centers for Medicare and Medicaid Services (CMS) has put forward a new set of proposals concerning the Medicare Drug Price Negotiation Program.
The proposed changes are designed with two primary objectives. First, they seek to codify the current requirements of the program, establishing them more formally within the regulatory framework. Second, the proposals aim to close any potential loopholes that could be exploited by drugmakers.
These modifications are intended to strengthen the overall structure and implementation of the Medicare Drug Price Negotiation Program.
According to The Hill, these changes could have implications for how drug prices are negotiated under Medicare.
